BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28394868)

  • 1. Surgeon Age in Relation to Prognosis After Esophageal Cancer Resection.
    Markar SR; Mackenzie H; Lagergren P; Lagergren J
    Ann Surg; 2018 Jul; 268(1):100-105. PubMed ID: 28394868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. University hospital status and prognosis following surgery for esophageal cancer.
    Markar SR; Wahlin K; Lagergren P; Lagergren J
    Eur J Surg Oncol; 2016 Aug; 42(8):1191-5. PubMed ID: 27288216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgeon Volume and Surgeon Age in Relation to Proficiency Gain Curves for Prognosis Following Surgery for Esophageal Cancer.
    Gottlieb-Vedi E; Mackenzie H; van Workum F; Rosman C; Lagergren P; Markar S; Lagergren J
    Ann Surg Oncol; 2019 Feb; 26(2):497-505. PubMed ID: 30324469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of lymph node removal during esophageal cancer surgery and survival.
    van der Schaaf M; Johar A; Wijnhoven B; Lagergren P; Lagergren J
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25748792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
    Kauppila JH; Wahlin K; Lagergren P; Lagergren J
    Int J Cancer; 2019 Mar; 144(6):1284-1291. PubMed ID: 30168595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. University hospital status and surgeon volume and risk of reoperation following surgery for esophageal cancer.
    Kauppila JH; Wahlin K; Lagergren P; Lagergren J
    Eur J Surg Oncol; 2018 May; 44(5):632-637. PubMed ID: 29548804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study.
    Derogar M; Sadr-Azodi O; Johar A; Lagergren P; Lagergren J
    J Clin Oncol; 2013 Feb; 31(5):551-7. PubMed ID: 23295792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time shift in early postoperative mortality after oesophagectomy for cancer.
    Rutegård M; Lagergren P; Johar A; Lagergren J
    Ann Surg Oncol; 2015 Sep; 22(9):3144-9. PubMed ID: 25649859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekday of Esophageal Cancer Surgery and Its Relation to Prognosis.
    Lagergren J; Mattsson F; Lagergren P
    Ann Surg; 2016 Jun; 263(6):1133-7. PubMed ID: 26565140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical complications and long-term survival after esophagectomy for cancer in a nationwide Swedish cohort study.
    Rutegård M; Lagergren P; Rouvelas I; Mason R; Lagergren J
    Eur J Surg Oncol; 2012 Jul; 38(7):555-61. PubMed ID: 22483704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extent of Lymphadenectomy and Prognosis After Esophageal Cancer Surgery.
    Lagergren J; Mattsson F; Zylstra J; Chang F; Gossage J; Mason R; Lagergren P; Davies A
    JAMA Surg; 2016 Jan; 151(1):32-9. PubMed ID: 26331431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications during neoadjuvant therapy and prognosis following surgery for esophageal cancer.
    Markar SR; Johar A; Maisey N; Lagergren P; Lagergren J
    Dis Esophagus; 2018 May; 31(5):. PubMed ID: 29293984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Proficiency Gain and Survival After Esophagectomy for Cancer.
    Markar SR; Mackenzie H; Lagergren P; Hanna GB; Lagergren J
    J Clin Oncol; 2016 May; 34(13):1528-36. PubMed ID: 26951311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based esophageal cancer survival after resection without neoadjuvant therapy: an update.
    Rutegård M; Charonis K; Lu Y; Lagergren P; Lagergren J; Rouvelas I
    Surgery; 2012 Nov; 152(5):903-10. PubMed ID: 22657730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of diabetes and other co-morbidities on survival after esophageal cancer surgery in a population-based study.
    Backemar L; Djärv T; Wikman A; Johar A; Ross P; Lagergren P; Lagergren J
    Am J Surg; 2013 Oct; 206(4):539-43. PubMed ID: 23809996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of co-morbidity on mortality after oesophageal cancer surgery.
    Backemar L; Lagergren P; Johar A; Lagergren J
    Br J Surg; 2015 Aug; 102(9):1097-105. PubMed ID: 26059747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doubling of 30-Day Mortality by 90 Days After Esophagectomy: A Critical Measure of Outcomes for Quality Improvement.
    In H; Palis BE; Merkow RP; Posner MC; Ferguson MK; Winchester DP; Pezzi CM
    Ann Surg; 2016 Feb; 263(2):286-91. PubMed ID: 25915912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgeon Volume and Cancer Esophagectomy, Gastrectomy, and Pancreatectomy: A Population-based Study in England.
    Mamidanna R; Ni Z; Anderson O; Spiegelhalter SD; Bottle A; Aylin P; Faiz O; Hanna GB
    Ann Surg; 2016 Apr; 263(4):727-32. PubMed ID: 26501701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative esophageal stenting and short-term outcomes of surgery for esophageal cancer in a population-based study from Finland and Sweden.
    Helminen O; Kauppila JH; Kytö V; Gunn J; Lagergren J; Sihvo E
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30855081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.